These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Strategies for managing the patient with acute non-Q-wave myocardial infarction. Boden WE Clin Cardiol; 1989 Jul; 12(7 Suppl 3):III33-40. PubMed ID: 2575020 [TBL] [Abstract][Full Text] [Related]
9. Management of non-Q-wave myocardial infarction: role of diltiazem versus beta-blocker therapy. Boden WE J Cardiovasc Pharmacol; 1990; 16 Suppl 6():S55-60. PubMed ID: 1707117 [TBL] [Abstract][Full Text] [Related]
10. Thrombolysis and its sequelae. Calcium antagonists as potential adjunctive therapy. Roberts R Circulation; 1989 Dec; 80(6 Suppl):IV93-101. PubMed ID: 2513147 [TBL] [Abstract][Full Text] [Related]
11. PROTECT (Prospective Reinfarction Outcomes in the Thrombolytic Era Cardizem CD Trial): a randomized, double-blind clinical trial of diltiazem versus atenolol in secondary prophylaxis post non-Q wave myocardial infarction. Goodman S; Hill C; Bata I; Fung A; Higginson L; Lam J; Massel D; McCans J; Nasmith J; Stanton E; Thompson C; Warnica W; Langer A Can J Cardiol; 1996 Nov; 12(11):1183-90. PubMed ID: 9191511 [TBL] [Abstract][Full Text] [Related]
12. [Therapeutic measures following acute myocardial infarct: differential use of PTCA, surgery and drugs]. Noll G; Kaufmann U; Wenzel RR; Lüscher TF Schweiz Med Wochenschr; 1996 Feb; 126(5):164-76. PubMed ID: 8685687 [TBL] [Abstract][Full Text] [Related]
13. Secondary prevention with calcium channel-blocking drugs in patients after myocardial infarction: a critical review. Moss AJ Circulation; 1987 Jun; 75(6 Pt 2):V148-53. PubMed ID: 3552311 [TBL] [Abstract][Full Text] [Related]
14. [Do calcium inhibitors have any role in secondary prevention of myocardial infarction?]. Vacheron A; Tabone X Ann Cardiol Angeiol (Paris); 1992 Jun; 41(6):343-7. PubMed ID: 1359828 [TBL] [Abstract][Full Text] [Related]
15. Calcium antagonists in the therapy of acute myocardial infarction. Stazi F; Verde M; Stazi C; Di Gennaro M Minerva Cardioangiol; 2000; 48(1-2):29-38. PubMed ID: 10829585 [TBL] [Abstract][Full Text] [Related]
16. Role of calcium antagonists in progression of arteriosclerosis. Evidence from animal experiments and clinical experience. Part II. Clinical experience with preventive effects of calcium channel blockers in atheromatous coronary artery disease. Just H; Frey M Basic Res Cardiol; 1994; 89 Suppl 1():177-84. PubMed ID: 7945172 [TBL] [Abstract][Full Text] [Related]
17. [Which anti-ischemic treatment can be prescribed during and after the acute phase of myocardial infarction?]. Delahaye F; Genoud JL; Colin C; Landrivon G; Ecochard R; Desseigne P; Pinzani A; André-Fouët X; Delaye J Arch Mal Coeur Vaiss; 1992 Nov; 85(11):1567-74. PubMed ID: 1363772 [TBL] [Abstract][Full Text] [Related]
18. [Pharmacologic limitation of the size of the myocardial infarction (excluding thrombolysis)]. Zannad F; Gilgenkrantz JM; Royer RJ Ann Cardiol Angeiol (Paris); 1985; 34(7):467-73. PubMed ID: 2865926 [TBL] [Abstract][Full Text] [Related]
19. Calcium channel blockers: an evidence-based review. Waters D Can J Cardiol; 1997 Aug; 13(8):757-66. PubMed ID: 9284842 [TBL] [Abstract][Full Text] [Related]
20. Medical prophylaxis for the post myocardial infarct patient. Cohen LS Cardiol Clin; 1988 Feb; 6(1):173-8. PubMed ID: 2901909 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]